-+ 0.00%
-+ 0.00%
-+ 0.00%

IAMBIC THERAPEUTICS - MORE THAN HALF OF PARTICIPANTS AT 960 MG REMAIN ON STUDY BEYOND ONE YEAR

Reuters·10/26/2026 12:01:39

Please log in to view news